Fortitude Family Office’s MaxCyte MXCT Stock Holding History

Fortitude Family Office’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17	Sell	15 -197	-93%	-$242	﹤0.01%	2622
2026 Q2	$261	Buy	+212	New	+$211	﹤0.01%	2079
2026 Q1	–	Sell	-1,837	Closed	-$2.85K	–	2013
2025 Q4	$2.85K	Buy	+1,837	New	+$2.93K	﹤0.01%	1031
2025 Q3	–	Sell	-693	Closed	-$1.51K	–	2087
2025 Q2	$1.51K	Buy	+693	New	+$1.68K	﹤0.01%	1329

Other funds holding MXCT

KWMG LLC Overland Park, Kansas $1.39B AUM 24.28% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Fortitude Family Office's MXCT Position: Q3 2026 in Review

Fortitude Family Office reduced its MaxCyte (MXCT) stake by 93% in Q3 2026, selling an estimated $242 and leaving 15 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #2622.

Fortitude Family Office first reported a position in MXCT in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.85K in Q4 2025. 7 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

Fortitude Family Office held 15 shares of MaxCyte worth $17 as of Q3 2026.
Fortitude Family Office sold 197 MaxCyte shares in Q3 2026, an estimated $242.
MaxCyte made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2622 holding.
Fortitude Family Office first reported a position in MaxCyte in Q2 2025 and has held it in 4 quarters since.
Fortitude Family Office's MaxCyte position peaked at $2.85K in Q4 2025.
7 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.